Singh N, Handa S, Mahajan R, Sachdeva N, et al. Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus. Clin Exp Dermatol 2022;47:1508-1516.
PMID: 35384021